1572
MI related to the use of activated and non-activated PCCs predominantly affects young patients who often have no preceding history of, or risk factors for, MI and tends to be associated with large cumulative doses of concentrate.
 young patients who often have no preceding history of, or risk factors for, MI: Subject; young: Subject.Age; MI: Effect; activated and non-activated PCCs: Treatment; large cumulative doses of concentrate: Treatment; non-activated PCCs: Treatment.Drug; activated: Treatment.Drug; PCCs: Treatment.Drug; large cumulative doses: Treatment.Dosage
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 young patients who often have no preceding history of, or risk factors for, MI: Subject; young: Subject.Age; MI: Effect; activated and non-activated PCCs: Treatment; large cumulative doses of concentrate: Treatment; non-activated PCCs: Treatment.Drug; activated: Treatment.Drug; PCCs: Treatment.Drug; large cumulative doses: Treatment.Dosage